Keiko Ohgino

20PUBLICATIONS
77CO-AUTHORS
Predictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 28, 2025
Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer.

Kaito Yano, Kaoru Kaseda, Kohei Nakamura

|Aug 04, 2025
Clinical Application of In-House Comprehensive Genomic Profiling for Thoracic Cancer: Insights From a Japanese Hospital.

Hatsuyo Takaoka, Hideki Terai, Kohei Nakamura

|Jun 27, 2025
A Case of PMR-Like irAE Developing After Treatment With Ipilimumab and Nivolumab for Lung Cancer.

Ryuichi Utsumi, Hideki Terai, Tetsuya Arai

|May 11, 2025
Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma.

Taro Shinozaki, Kazuhiro Togasaki, Junko Hamamoto

|Apr 30, 2025
An organoid library unveils subtype-specific IGF-1 dependency via a YAP-AP1 axis in human small cell lung cancer.

Takahiro Fukushima, Kazuhiro Togasaki, Junko Hamamoto

|Jan 08, 2025
Real-World Efficacy and Safety of Atezolizumab for Advanced Non-Small Cell Lung Cancer in Japan: A Retrospective Multicenter Analysis.

Masahiko Okada, Keiko Ohgino, Kohei Horiuchi

Pageof 4

Frequent Collaborators

4 joint publications

Katsura Emoto

3 joint publications

Hiroyuki Yasuda

3 joint publications

Kohei Nakamura

3 joint publications

Toshiro Sato